Iomeron

Iomeprol, the active ingredient in Iomeron, is a iodinated non‑ionic contrast agent presented as a solution for injection for intra‑arterial, intra‑articular, and intrathecal use. It enhances radiographic visualization of vascular and tissue structures during diagnostic imaging procedures. GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iomeprol is used as a contrast medium in radiographic procedures that require vascular, intra‑articular, or intrathecal imaging.

Angiography: provides clear visualization of blood vessels. Arthrography: enhances imaging of joint spaces. Myelography: delineates the spinal canal and nerve roots. Other radiographic procedures: improves contrast of soft‑tissue structures during CT or fluoroscopy.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warm sensation or flushing at the injection site - Nausea or vomiting - Metallic taste or mild throat irritation - Headache - Mild urticaria or skin redness - Transient hypotension

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Contrast‑induced nephropathy leading to acute kidney injury - Severe hypotension or cardiovascular collapse - Cardiac arrhythmias - Seizures or neurologic disturbances - Persistent skin necrosis at the injection site

Prior to administration, clinicians should assess patient-specific risk factors and follow recommended safety measures.

Assess renal function: evaluate serum creatinine and eGFR before use. Screen for iodine allergy: obtain a detailed history of prior contrast reactions. Consider thyroid status: avoid in uncontrolled hyperthyroidism. Use lowest effective dose: tailor volume to the imaging protocol and patient size. Monitor vital signs: observe the patient during and after injection for any adverse events. Store below 25°C: keep in original packaging, protect from light and moisture.

Iomeron can interact with certain medications and other contrast agents, requiring careful management.

Major Interactions (Avoid): - Repeat administration of iodinated contrast within 24 hours: increases risk of nephrotoxicity. - Metformin in patients with impaired renal function: may precipitate lactic acidosis. - Thyroid hormone therapy: can exacerbate thyroid dysfunction.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance renal clearance and affect contrast elimination. - ACE inhibitors or ARBs: potential for additive hypotensive effects. - NSAIDs: may compound renal stress, especially in susceptible patients.